Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Nkarta
(NASDAQ:NKTX)
Intraday
$7.77
0.38
[5.14%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$7.77
0.38
[5.14%]
Last update: 11:00AM
Get Real Time Here
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Nkarta Stock (NASDAQ:NKTX)
Nkarta Stock (NASDAQ: NKTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, April 12, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Apr 12, 2024, 8:09AM
Thursday, April 11, 2024
Small-Cap Firm Century Therapeutics' Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing
Vandana Singh
-
Apr 11, 2024, 4:24PM
Wednesday, April 10, 2024
Needham Reiterates Buy on Nkarta, Maintains $15 Price Target
Benzinga Newsdesk
-
Apr 10, 2024, 7:32AM
Tuesday, March 26, 2024
Canaccord Genuity Maintains Buy on Nkarta, Raises Price Target to $16
Benzinga Newsdesk
-
Mar 26, 2024, 7:07AM
Monday, March 25, 2024
Nasdaq Turns Higher; Akanda Shares Plunge
Avi Kapoor
-
Mar 25, 2024, 3:00PM
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Mar 25, 2024, 2:44PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Mar 25, 2024, 1:30PM
HC Wainwright & Co. Maintains Buy on Nkarta, Raises Price Target to $22
Benzinga Newsdesk
-
Mar 25, 2024, 12:33PM
Crude Oil Moves Higher; US New Home Sales Fall In February
Avi Kapoor
-
Mar 25, 2024, 11:54AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Mar 25, 2024, 9:05AM
Nkarta shares are trading higher after the company priced $240 million underwritten offering.
Benzinga Newsdesk
-
Mar 25, 2024, 6:45AM
Nkarta Prices Its Underwritten Offering Of 21M Shares At $10.00/Share And Pre-funded Warrants To Purchase 3M Shares At $9.9999/Warrant, With Gross Proceeds Of Approximately $240.1M
Benzinga Newsdesk
-
Mar 25, 2024, 6:34AM
Friday, March 22, 2024
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Mar 22, 2024, 2:39PM
Stocks Level Off, S&P 500 Nears Best Week Of 2024, NVIDIA Rallies For 11th Week, Bitcoin Sinks: What's Driving Markets Friday?
Piero Cingari
-
Mar 22, 2024, 1:55PM
Why Is Cancer Drug-Developer Nkarta Stock Trading Lower On Friday?
Vandana Singh
-
Mar 22, 2024, 1:49PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Mar 22, 2024, 1:31PM
Mizuho Maintains Buy on Nkarta, Lowers Price Target to $25
Benzinga Newsdesk
-
Mar 22, 2024, 10:29AM
Nkarta shares are trading lower after the company reported Q4 financial results. Following earnings, Raymond James downgraded the stock from Strong Buy to Outperform.
Benzinga Newsdesk
-
Mar 22, 2024, 9:11AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Mar 22, 2024, 9:06AM
FedEx To Rally Over 32%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
-
Mar 22, 2024, 8:53AM
These Analysts Revise Their Forecasts On Nkarta After Q4 Results
Avi Kapoor
-
Mar 22, 2024, 8:17AM
Needham Reiterates Buy on Nkarta, Maintains $15 Price Target
Benzinga Newsdesk
-
Mar 22, 2024, 7:49AM
HC Wainwright & Co. Maintains Buy on Nkarta, Lowers Price Target to $20
Benzinga Newsdesk
-
Mar 22, 2024, 7:05AM
Raymond James Downgrades Nkarta to Outperform, Raises Price Target to $16
Benzinga Newsdesk
-
Mar 22, 2024, 5:48AM
Thursday, March 21, 2024
Nkarta Q4 EPS $(0.57) Beats $(0.59) Estimate
Happy Mohamed
-
Mar 21, 2024, 4:04PM
Tuesday, March 05, 2024
Mizuho Maintains Buy on Nkarta, Raises Price Target to $31
Benzinga Newsdesk
-
Mar 5, 2024, 8:58AM
Friday, January 19, 2024
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Jan 19, 2024, 1:05PM
Tuesday, January 16, 2024
HC Wainwright & Co. Maintains Buy on Nkarta, Raises Price Target to $22
Benzinga Newsdesk
-
Jan 16, 2024, 4:01PM
Tuesday, January 09, 2024
Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor
-
Jan 9, 2024, 6:36AM
Monday, January 08, 2024
What's Going On With Cancer Drug-Developer Nkarta Stock?
Erica Kollmann
-
Jan 8, 2024, 3:51PM
Dow Surges Over 100 Points; Commercial Metals Posts Upbeat Q1 Results
Avi Kapoor
-
Jan 8, 2024, 2:33PM
Nkarta shares are trading higher after the company announced an updated corporate presentation to reflect certain business and strategic updates.
Benzinga Newsdesk
-
Jan 8, 2024, 1:39PM
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Jan 8, 2024, 1:36PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Jan 8, 2024, 12:30PM
Nkarta Announces Updated Corporate Presentation To Reflect Business And Strategic Updates; Cash And Cash Equivalents $278.4M As Of Sept. 30, 2023
Benzinga Newsdesk
-
Jan 8, 2024, 9:01AM
Wednesday, January 03, 2024
Pinstripes, SoFi Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
-
Jan 3, 2024, 6:14AM
Tuesday, December 12, 2023
Analyst Ratings for Nkarta
Benzinga Insights
-
Dec 12, 2023, 10:00AM
Needham Reiterates Buy on Nkarta, Maintains $15 Price Target
Benzinga Newsdesk
-
Dec 12, 2023, 6:45AM
Sunday, December 10, 2023
Nkarta Presented NKX101 Clinical Data Saturday At 2023 ASH Meeting
Charles Gross
-
Dec 10, 2023, 7:29AM
Thursday, November 16, 2023
The Latest Analyst Ratings for Nkarta
Benzinga Insights
-
Nov 16, 2023, 1:00PM
Mizuho Maintains Buy on Nkarta, Lowers Price Target to $9
Benzinga Newsdesk
-
Nov 16, 2023, 12:32PM
Thursday, November 09, 2023
Nkarta Q3 EPS $(0.52) Beats $(0.73) Estimate
Benzinga Newsdesk
-
Nov 9, 2023, 5:01PM
These Biotech Stocks Could Double Your Money, According To Analysts
Aditi Ganguly
-
Nov 9, 2023, 9:38AM
Thursday, October 19, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Oct 19, 2023, 9:06AM
Wednesday, October 18, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023
Benzinga Insights
-
Oct 18, 2023, 11:00AM
Visa To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Lisa Levin
-
Oct 18, 2023, 8:04AM
Analyst Expectations for Nkarta's Future
Benzinga Insights
-
Oct 18, 2023, 8:00AM
HC Wainwright & Co. Maintains Buy on Nkarta, Lowers Price Target to $10
Benzinga Newsdesk
-
Oct 18, 2023, 7:47AM
Needham Reiterates Buy on Nkarta, Maintains $15 Price Target
Benzinga Newsdesk
-
Oct 18, 2023, 6:48AM
Raymond James Upgrades Nkarta to Strong Buy, Announces $13 Price Target
Benzinga Newsdesk
-
Oct 18, 2023, 4:22AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch